Unknown

Dataset Information

0

The modular network structure of the mutational landscape of Acute Myeloid Leukemia.


ABSTRACT: Acute myeloid leukemia (AML) is associated with the sequential accumulation of acquired genetic alterations. Although at diagnosis cytogenetic alterations are frequent in AML, roughly 50% of patients present an apparently normal karyotype (NK), leading to a highly heterogeneous prognosis. Due to this significant heterogeneity, it has been suggested that different molecular mechanisms may trigger the disease with diverse prognostic implications. We performed whole-exome sequencing (WES) of tumor-normal matched samples of de novo AML-NK patients lacking mutations in NPM1, CEBPA or FLT3-ITD to identify new gene mutations with potential prognostic and therapeutic relevance to patients with AML. Novel candidate-genes, together with others previously described, were targeted resequenced in an independent cohort of 100 de novo AML patients classified in the cytogenetic intermediate-risk (IR) category. A mean of 4.89 mutations per sample were detected in 73 genes, 35 of which were mutated in more than one patient. After a network enrichment analysis, we defined a single in silico model and established a set of seed-genes that may trigger leukemogenesis in patients with normal karyotype. The high heterogeneity of gene mutations observed in AML patients suggested that a specific alteration could not be as essential as the interaction of deregulated pathways.

SUBMITTER: Ibanez M 

PROVIDER: S-EPMC6179200 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications


Acute myeloid leukemia (AML) is associated with the sequential accumulation of acquired genetic alterations. Although at diagnosis cytogenetic alterations are frequent in AML, roughly 50% of patients present an apparently normal karyotype (NK), leading to a highly heterogeneous prognosis. Due to this significant heterogeneity, it has been suggested that different molecular mechanisms may trigger the disease with diverse prognostic implications. We performed whole-exome sequencing (WES) of tumor-  ...[more]

Similar Datasets

| S-EPMC3980839 | biostudies-other
| S-EPMC9883550 | biostudies-literature
| S-EPMC5243866 | biostudies-literature
| S-EPMC9367218 | biostudies-literature
| S-EPMC10713399 | biostudies-literature
| S-EPMC8733030 | biostudies-literature
| S-EPMC5907936 | biostudies-literature
| S-EPMC4873364 | biostudies-literature
| S-EPMC8209618 | biostudies-literature
| S-EPMC6316310 | biostudies-literature